CLINICAL INVESTIGATION OF CISPLATINE/PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Watanabe, K. [1 ]
Okuma, Y. [1 ]
Nakahara, Y. [1 ]
Yomota, M. [1 ]
Takagi, Y. [1 ]
Hosomi, Y. [1 ]
Okamura, T. [1 ]
机构：
[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt460.21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [21] CLINICAL SIGNIFICANCE OF HYPERPIGMENTATION DUE TO PEMETREXED TREATMENT IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN CHINA
    Hu, Qiong
    Li, Aiwu
    Ren, Shengxiang
    Chen, Xiaoxia
    Gao, Guanghui
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S564 - S564
  • [22] Tolerance and efficacy of branded generic pemetrexed maintenance in Indian patients of metastatic non-squamous non-small-cell lung cancer
    Sehrawat, Amit
    Parthasarathy, K. M.
    Gupta, Deni
    Gera, Arun
    INDIAN JOURNAL OF CANCER, 2019, 56 (03) : 276 - 278
  • [23] Clinical Study of Pemetrexed as the First-line Treatment in Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Pu Xiaolin
    Wang Jun
    Li Wei
    Lu Binbin
    Wang Zhaoxia
    Yang Min
    Fan Weifei
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (04): : 205 - 209
  • [24] Bevacizumab, When Added To Pemetrexed/platinum, Prolongs Survival In Previously Untreated Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer In Japan
    Mouri, A.
    Arimoto, Y.
    Takeoka, S.
    Honma, C.
    Fukusumi, M.
    Hamamoto, Y.
    Kamimura, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [25] Pemetrexed A Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer
    Baldwin, Claudine M.
    Perry, Caroline M.
    DRUGS, 2009, 69 (16) : 2279 - 2302
  • [26] Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
    Kawano, Yuko
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Tanimoto, Azusa
    Nishizawa, Hironari
    Ichikawa, Atsuo
    Sakatani, Toshio
    Nakatomi, Katsumi
    Hagiwara, Sachiko
    Ninomiya, Hironori
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2013, 33 (08) : 3327 - 3333
  • [27] Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
    Ben Rothwell
    Christopher Kiff
    Caroline Ling
    Thor-Henrik Brodtkorb
    PharmacoEconomics - Open, 2021, 5 : 251 - 260
  • [28] Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction
    van Kruijsdijk, R. C. M.
    Visseren, F. L. J.
    Boni, L.
    Groen, H. J. M.
    Dingemans, A. M. C.
    Aerts, J. G. J. V.
    van der Graaf, Y.
    Ardizzoni, A.
    Smit, E. F.
    ANNALS OF ONCOLOGY, 2016, 27 (07) : 1280 - 1286
  • [29] Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
    Rothwell, Ben
    Kiff, Christopher
    Ling, Caroline
    Brodtkorb, Thor-Henrik
    PHARMACOECONOMICS-OPEN, 2021, 5 (02) : 251 - 260
  • [30] Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer
    Belani, Chandra P.
    Yamamoto, Nobuyuki
    Bondarenko, Igor M.
    Poltoratskiy, Artem
    Novello, Silvia
    Tang, Jie
    Bycott, Paul
    Niethammer, Andreas G.
    Ingrosso, Antonella
    Kim, Sinil
    Scagliotti, Giorgio V.
    BMC CANCER, 2014, 14
12345